Response data (n = 446)
| Response . | Excluding CBF (n = 430), n (%) . | CBF (n = 16), n (%) . | Total (n = 446), n (%) . |
|---|---|---|---|
| Complete response | 193 (45) | 10 (63) | 203 (46) |
| Partial response | 3 (1) | 0 | 3 (1) |
| Marrow complete response, low platelets | 12 (3) | 3 (19) | 15 (4) |
| Resistant disease | 88 (20) | 0 | 88 (20) |
| Induction mortality | |||
| ≤ 2 wk | 63 (15) | 2 (13) | 65 (15) |
| 4 wk | 111 (26) | 3 (19) | 114 (26) |
| 8 wk | 154 (36) | 4 (21) | 158 (35) |
| Response . | Excluding CBF (n = 430), n (%) . | CBF (n = 16), n (%) . | Total (n = 446), n (%) . |
|---|---|---|---|
| Complete response | 193 (45) | 10 (63) | 203 (46) |
| Partial response | 3 (1) | 0 | 3 (1) |
| Marrow complete response, low platelets | 12 (3) | 3 (19) | 15 (4) |
| Resistant disease | 88 (20) | 0 | 88 (20) |
| Induction mortality | |||
| ≤ 2 wk | 63 (15) | 2 (13) | 65 (15) |
| 4 wk | 111 (26) | 3 (19) | 114 (26) |
| 8 wk | 154 (36) | 4 (21) | 158 (35) |
CBF indicates core binding factor leukemia.